Shopping Cart

Remove All

Your shopping cart is currently empty

Proceed to checkout Continue shopping

FR167344 free base

Name: FR167344 free base
Brand: TargetMol
SKU: T15347
Rating: 4.5 (1 reviews)

Copy Product Info

😃Good

Catalog No. T15347Cas No. 215258-13-2

FR167344 free base is an orally active, nonpeptide antagonist of the bradykinin receptor B2, exhibiting high-affinity binding (IC50: 65 nM) and showing no binding affinity for the B1 receptor.

FR167344 free base

Copy Product Info

😃Good

Catalog No. T15347Cas No. 215258-13-2

FR167344 free base is an orally active, nonpeptide antagonist of the bradykinin receptor B2, exhibiting high-affinity binding (IC50: 65 nM) and showing no binding affinity for the B1 receptor.

Pack Size	Price	USA Warehouse	Global Warehouse
25 mg	$2,570	3-6 months	3-6 months
50 mg	$3,380	3-6 months	3-6 months
100 mg	$4,600	3-6 months	3-6 months

Add to Cart

Add to Quotation

In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]

All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Questions

Resource Download

Product Introduction

Bioactivity

Description	FR167344 free base is an orally active, nonpeptide antagonist of the bradykinin receptor B2, exhibiting high-affinity binding (IC50: 65 nM) and showing no binding affinity for the B1 receptor.
Targets&IC50	Bradykinin receptor B2:65 nM
In vitro	FR167344 shows no stimulatory effects on PI hydrolysis. FR167344 inhibits the B2 receptor-mediated phosphatidylinositol (PI) hydrolysis and produces a concentration-dependent rightward shift in the dose-response curve to bradykinin, in competitive experiments using membranes prepared from Chinese hamster ovary cells expressing the bradykinin receptor subtypes. This shift is accompanied by a progressive reduction of maximal response. Estimated pA2 values for the antagonism of bradykinin-induced PI hydrolysis by FR167344 is 8.0 [1].
In vivo	FR167344 (p.o.; 2h; carrageenin injection) inhibits carrageenin-induced paw oedema in rats (ID50: 2.7 mg/kg). FR167344 (p.o.) inhibits kaolin-induced writhing in mice (ID50: 2.8 mg/kg in 10 min writhing and 4.2 mg/kg in 15 min writhing). FR167344(p.o.) inhibits caerulein-induced pancreatic oedema (ID50: 13.8 mg/kg) and it also increases in amylase and lipase of blood samples (ID50: 10.3 and 7.4 mg/kg, respectively, in rats) [2].

Chemical Properties

Molecular Weight	673.38
Formula	C₃₀H₂₈BrCl₂N₅O₄
Cas No.	215258-13-2
Smiles	O(CC1=C(Cl)C(N(C(CNC(/C=C/C2=CC=C(C(N(C)C)=O)C=C2)=O)=O)C)=CC=C1Cl)C=3C=4N(C(Br)=C(C)N4)C=CC3
Relative Density.	1.43 g/cm3 (Predicted)

Storage & Solubility Information

Storage

Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.

Calculator

Molarity Calculator
Dilution Calculator
Reconstitution Calculator
Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:

For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments

and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent

10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH₂O , the resulting working solution concentration would be 2 mg/mL.

Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSO TargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSO TargetMol | reagent stock solution to 400 μL PEG300 and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH₂O TargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.

All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc